Brean Murray Carret & Co. Raises Price Target on Immunogen (IMGN), Maintains Buy Rating
Tweet Send to a Friend
Brean Murray Carret & Co. is maintaining their Buy rating rating on shares of Immunogen Inc. (NASDAQ: IMGN) as they ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
